Search results
- Over the last two years, the federal government has committed more than $1.8 billion to 33 projects in biomanufacturing, vaccines, and therapeutics, strengthening our domestic ability to respond to pandemics, supporting innovations in life sciences, and creating and maintaining thousands of highly skilled jobs.
www.pm.gc.ca/en/news/news-releases/2023/02/27/creating-good-jobs-health-research-and-innovation
People also ask
What is Canada's biomanufacturing and life science strategy?
Why should Canada invest in life sciences & biomanufacturing?
What is Canada doing about science?
Does Canada have a made-in-Canada Life Sciences & biomanufacturing sector?
Why is Canada investing in the life sciences sector?
What is Canada's 'Life Science Innovation Strategy'?
These objectives will be supported by upstream federal enabling measures, such as support for clinical trials, training and skills development for the life sciences labor market, modern regulations and commercialization of Canadian innovations.
- News release
- Quotes
- Quick facts
- Stay connected
Today, the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, and the Honourable Patty Hajdu, Minister of Health, launched the Biomanufacturing and Life Sciences Strategy. This means more than $2.2 billion over seven years from Budget 2021 to continue growing a strong and competitive sector and to ensure our country is prepared for future pandemics.
Investments will grow a strong, competitive biomanufacturing and life sciences sector in Canada and protect Canadians against future epidemics and pandemics
July 28, 2021 – Vancouver, British Columbia
Canada has an impressive history in biomanufacturing and life sciences., from the discovery of insulin one hundred years ago, to the Canadian scientists who were instrumental in developing the polio and Ebola vaccines, to the Canadian veterinarian who discovered the first blood thinner.
However, a 40-year decline in the sector left Canada without the large-scale and flexible biomanufacturing capacity necessary to quickly produce a COVID-19 vaccine when the pandemic hit. This is why the Government of Canada has worked tirelessly to rebuild Canada’s domestic biomanufacturing sector by focusing on both short-term strategic solutions and a long‑term vision. The Government of Canada has already invested over $1.2 billion to rebuild Canada’s vaccine, therapeutics and biomanufacturing capacity right here at home.
As Canadians begin to look towards a post-pandemic future, the Government of Canada continues to build resiliency in Canada’s biomanufacturing and life sciences sector as part of the government’s recovery plan. Through strategic investments informed by experts, we are strengthening Canada’s biomanufacturing and life sciences sector, improving economic growth and ensuring pandemic readiness for years to come.
“ Keeping Canadians safe and healthy by making sure they have access to life-saving medicines like critical vaccines is vitally important. By launching this strategy today, our government is helping Canadian companies advance made-in-Canada solutions to global challenges. We are strengthening Canada’s talent pipeline and creating good jobs, while supporting the growth of the biomanufacturing and life sciences industry in Canada that will ensure a safe future for all of us.”
- The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry
“The COVID-19 pandemic has shown us just how important it is to build up Canada’s capacity to produce vaccines and therapeutics. This biomanufacturing and life sciences strategy, complemented by Canada’s world-class clinical trial and regulatory system, will not only support the future health and safety of Canadians, but also offer opportunities in health innovation for drugs and medical devices.”
- The Honourable Patty Hajdu, Minister of Health
•Growing Canada’s life sciences and biomanufacturing sector is a priority that goes beyond responding to COVID-19. The government’s investments in this growing sector support thousands of good, middle-class jobs while improving Canada’s pandemic preparedness for years to come.
Budget 2021 provides a total of $2.2 billion over seven years towards growing a vibrant domestic life sciences sector and improving pandemic preparedness. This provides foundational investments to help build Canada’s talent pipeline and research systems, as well as foster the growth of Canadian life sciences firms, including:
•$59.2 million over three years, starting in 2021–22, for the Vaccine and Infectious Disease Organization to develop its vaccine candidates and expand its facility in Saskatoon
•$500 million over four years, starting in 2021–22, for the Canada Foundation for Innovation to support the bioscience capital and infrastructure needs of post-secondary institutions and research hospitals
•$250 million over four years, starting in 2021–22, for the federal research granting councils to create a new tri-council biomedical research fund
•$92 million over four years, starting in 2021–22, for adMare BioInnovations to support company creation, scale-up and training activities in the life sciences sector
Ensuring access to critical vaccines, therapeutics and other life-saving medicines is a priority for the Government of Canada. While Canada continues to respond to the current pandemic, we are also implementing a biomanufacturing and life sciences strategy to plan for the future.
Mar 30, 2022 · With the guidance of Canada’s Biomanufacturing and Life Sciences Strategy, the government is actively supporting the growth of a strong, competitive domestic life sciences sector, with cutting-edge biomanufacturing capabilities. Today, the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced a $92 ...
Mar 26, 2024 · Through Laboratories Canada, the Government of Canada is providing federal scientists and researchers with world-class, innovative and collaborative facilities to ensure they can not only keep pace with, but lead in the transformative changes facing science today and into the future.
- Public Services And Procurement Canada
Jul 28, 2021 · The Biomanufacturing and Life Sciences Strategy is driven by two objectives: to grow a strong, competitive domestic life sciences sector, with cutting-edge biomanufacturing capabilities, while...
Federal science and technology (S&T) plays a unique role in Canada’s science and innovation ecosystem, complementing the science done by academia and industry. Federal S&T supports evidence-based policy, legislation, regulations, and standards; informs responses to threats, opportunities, and emerging priorities; delivers public-good services ...
